|Articles|August 1, 2002
- Applied Clinical Trials-08-01-2002
Developing New Drugs in 1000 Days
Everybody wants faster cycles and and quicker turnarounds with NDAs. In the U.S., will it soon be possible to go from testing to approval in 1000 days?
Advertisement
Articles in this issue
almost 24 years ago
Cross-(Dys)Functional Teamsalmost 24 years ago
Checking In on Children, Checking Up on Filesalmost 24 years ago
eSource Reduxalmost 24 years ago
New User Fee Program Aims to Spur Drug Developmentalmost 24 years ago
Paper vs. Electronic DiariesAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy
2
Bringing the Voice of Clinical Practice and Patients into Drug Development
3
ACT Brief: Single Pivotal Trial Stakes, Configurable FSP Strategy, and G-CSF Biosimilar Portfolio Expansion
4
Beyond Eligibility: Making Trust and Behavioral Readiness Actionable in Clinical Trial Recruitment
5